Question 1

What are the potential benefits of using the FLEX-1 device compared to traditional methods?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 clinical trial (NCT02119845). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the risks or side effects associated with this device?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 clinical trial (NCT02119845). Contact the study team or your healthcare provider for specific answers.

Question 3

How will the procedure be performed and what can I expect during recovery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 clinical trial (NCT02119845). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options I should consider for my vascular access?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 clinical trial (NCT02119845). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of follow-up care will I need after the procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 clinical trial (NCT02119845). Contact the study team or your healthcare provider for specific answers.

What this study is about